China has been rolling out various measures to reform its healthcare system. Among these changes, the “two invoices system” has attracted much attention and is likely to affect the way pharmaceutical companies are structured and how they sell their drugs. Grace Xie, Henry Ngai and Thomas Li provide an overview of what is happening in China and how it will impact the pharmaceutical sector.
December 05 2016
